1. The Multifaceted Roles of Pyroptotic Cell Death Pathways in Cancer
   Man Wang et al, 2019, Cancers CrossRef
2. Induction of Pyroptosis and Its Implications in Cancer Management
   Yan-Yang Wang et al, 2019, Front. Oncol. CrossRef
3. Polyphyllin VI Induces Caspase-1-Mediated Pyroptosis via the Induction of ROS/NF-κB/NLRP3/GSDMD Signal Axis in Non-Small Cell Lung Cancer.
   Jin-Feng Teng et al, 2020, Cancers (Basel) CrossRef
4. RIPK3 is a novel prognostic marker for lower grade glioma and further enriches IDH mutational status subgrouping
   Guilherme Afonso Vergara et al, 2020, J Neurooncol CrossRef
5. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies
   Yunseo Woo et al, 2020, Cells CrossRef
6. Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks
   Ting-Yi Lin et al, 2021, Front. Immunol. CrossRef
7. Targeting Innate Immunity in Cancer Therapy
   Srikrishnan Rameshbabu et al, 2021, Vaccines CrossRef
8. Induction of Pyroptosis: A Promising Strategy for Cancer Treatment
   Lei Wang et al, 2021, Front. Oncol. CrossRef
9. GDC-0326 Enhances the Effects of 5-Fu in Colorectal Cancer Cells by Inducing Necroptotic Death
   Zizhen Zhang et al, 2021, OTT CrossRef
10. Gasdermin family proteins as a permeabilization factor of cell membrane in pyroptosis process
    Dorota Kuc-Ciepluch et al, 2021, Postepy Hig Med Dosw CrossRef
11. Differential Expression and Copy Number Variation of Gasdermin (GSDM) Family Members, Pore-Forming Proteins in Pyroptosis, in Normal and Malignant Serous Ovarian Tissue
    Caglar Berkel et al, 2021, Inflammation CrossRef
12. Pleural Fluid GSDMD Is a Novel Biomarker for the Early Differential Diagnosis of Pleural Effusion
    Pu Li et al, 2021, Front. Microbiol. CrossRef
13. Pyroptosis in Cancer: Friend or Foe?
    Xiuxia Lu et al, 2021, Cancers CrossRef
14. Pyroptosis, a New Breakthrough in Cancer Treatment.
    Dengqiang Wu et al, 2021, Front Oncol CrossRef
15. Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses
    Allan Scarpitta et al, 2021, Front. Oncol. CrossRef
16. Pyroptosis at the forefront of anticancer immunity
    Reid Loveless et al, 2021, J Exp Clin Cancer Res CrossRef
17. Comprehensive Analysis of the Immune Infiltrates of Pyroptosis in Kidney Renal Clear Cell Carcinoma
    Zhuolun Sun et al, 2021, Front. Oncol. CrossRef
18. A novel identified pyroptosis-related prognostic signature of colorectal cancer
    Chen Zheng et al, 2021, MBE CrossRef
19. Identification of a novel pyroptosis-related gene signature for predicting prognosis in bladder cancer
    Jianhan Fu et al, 2021, Cancer Investigation CrossRef
20. Gasdermin D Is a Novel Prognostic Biomarker and Relates to TMZ Response in Glioblastoma.
    Junhui Liu et al, 2021, Cancers (Basel) CrossRef
21. The Versatile Gasdermin Family: Their Function and Roles in Diseases
    Ju Zou et al, 2021, Front. Immunol. CrossRef
22. Genomic, Immunological, and Clinical Characterization of Pyroptosis in Ovarian Cancer
    Min Zhou et al, 2021, JIR CrossRef
23. Pyroptosis Regulators and Tumor Microenvironment Infiltration Characterization in Clear Cell Renal Cell Carcinoma
    Xi Zhang et al, 2022, Front. Oncol. CrossRef
24. Prognostic Implications of Pyroptosis-Related Gene Signatures in Lung Squamous Cell Carcinoma
    Tingting Li et al, 2022, Front. Pharmacol. CrossRef
25. Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas
    Zijian Zhou et al, 2022, Front. Genet. CrossRef
26. A Novel Risk Model Identified Based on Pyroptosis-Related lncRNA Predicts Overall Survival and Associates With the Immune Landscape of GC Patients
    Tingting Xu et al, 2022, Front. Genet. CrossRef
27. Inhibition of NEK7 Suppressed Hepatocellular Carcinoma Progression by Mediating Cancer Cell Pyroptosis
    Zilong Yan et al, 2022, Front. Oncol. CrossRef
28. Integratively Genomic Analysis Reveals the Prognostic and Immunological Characteristics of Pyroptosis and Ferroptosis in Pancreatic Cancer for Precision Immunotherapy
    Ting Yu et al, 2022, Front. Cell Dev. Biol. CrossRef
29. Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
    Hua Huang et al, 2022, Front. Oncol. CrossRef
30. Identification of a Pyroptosis-Related Gene Signature and Effect of Silencing the CHMP4C and CASP4 in Pancreatic Adenocarcinoma
    Yajun Chen et al, 2022, IJGM CrossRef
31. Ag/Au Bimetallic Nanoparticles Trigger Different Cell Death Pathways and Affect Damage Associated Molecular Pattern Release in Human Cell Lines
    Hector Katifelis et al, 2022, Cancers CrossRef
32. Role of Pyroptosis in Respiratory Diseases and its Therapeutic Potential
    Jingjing Liu et al, 2022, JIR CrossRef
33. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma
    Yulian Zhang et al, 2022, Front. Cell Dev. Biol. CrossRef
34. A Novel Classification Model for Lower-Grade Glioma Patients Based on Pyroptosis-Related Genes
    Yusheng Shen et al, 2022, Brain Sciences CrossRef
35. Lighting a Fire: Gasdermin-Mediated Pyroptosis Remodels the Glioma Microenvironment and Promotes Immune Checkpoint Blockade Response
    Yonghua Cai et al, 2022, Front. Immunol. CrossRef
36. A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma
    Kaibin Zhu et al, 2022, Front. Genet. CrossRef
37. Pan-Cancer Pyroptosis Analyses Identified Novel Immunology and Chemotherapy-Related Prognostic Signatures in Cancer Subtypes
    Canrong Li et al, 2022, Journal of Oncology CrossRef
38. Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
    Ming Zhong et al, 2022, Front. Genet. CrossRef
39. Pyroptosis in inflammation-related respiratory disease
    Yuanyu Feng et al, 2022, J Physiol Biochem CrossRef
40. The Potential Mechanism of HDAC1-Catalyzed Histone Crotonylation of Caspase-1 in Nonsmall Cell Lung Cancer
    Chuan Jiang et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
41. A systematic pan-cancer analysis of the gasdermin (GSDM) family of genes and their correlation with prognosis, the tumor microenvironment, and drug sensitivity
    Yufu Zheng et al, 2022, Front. Genet. CrossRef
42. Identification of a pyroptosis-related lncRNA signature in the regulation of prognosis, metabolism signals and immune infiltration in lung adenocarcinoma
    Shuyi Zhou et al, 2022, Front. Endocrinol. CrossRef
43. Secoisolariciresinol diglucoside induces pyroptosis by activating caspase‐1 to cleave GSDMD in colorectal cancer cells
    Tuo Chen et al, 2022, Drug Development Research CrossRef
44. Regulation of dietary polyphenols on cancer cell pyroptosis and the tumor immune microenvironment
    Xiaoxia Huang et al, 2022, Front. Nutr. CrossRef
45. Comprehensive analysis of pyroptotic gene prognostic signatures associated with tumor immune microenvironment and genomic mutation in breast cancer
    Hongfei Zhang et al, 2022, Front. Immunol. CrossRef
46. Classification of pyroptosis patterns and construction of a novel prognostic model for prostate cancer based on bulk and single-cell RNA sequencing
    Jianhan Fu et al, 2022, Front. Endocrinol. CrossRef
47. Gasdermin D: A potential mediator and prognostic marker of bladder cancer
    Randa El-Gamal et al, 2022, Front. Mol. Biosci. CrossRef
48. null
    Andreas B. den Hartigh et al, 2022 CrossRef
49. Pyroptosis in development, inflammation and disease
    Yuhong Pan et al, 2022, Front. Immunol. CrossRef
50. Identification and Validation of Three-Gene Signature in Lung Squamous Cell Carcinoma by Integrated Transcriptome and Methylation Analysis
    Guanghua Li et al, 2022, Journal of Oncology CrossRef
51. A pyroptosis‐related signature predicts prognosis and indicates immune microenvironment infiltration in glioma
    Jia Chen et al, 2022, Cancer Medicine CrossRef
52. Development of a prognostic prediction model based on a combined multi-omics analysis of head and neck squamous cell carcinoma cell pyroptosis-related genes
    Bin Chen et al, 2022, Front. Genet. CrossRef
53. Development and verification of a prognostic model for colon cancer on pyroptosis-related genes
    Zizhen Wu et al, 2022, Front. Genet. CrossRef
54. Construction and Verification of a Novel Pyroptosis-Related lncRNA Signature Associated with Immune Landscape in Gliomas
    Xiaoqiang Feng et al, 2022, Journal of Oncology CrossRef
55. Pyroptosis-Related Gene Signature Predicts the Prognosis of ccRCC Using TCGA and Single-Cell RNA Seq Database
    Ying Gan et al, 2022, Journal of Healthcare Engineering CrossRef
56. A novel refined pyroptosis and inflammasome-related genes signature for predicting prognosis and immune microenvironment in pancreatic ductal adenocarcinoma
    Jieliang Zuo et al, 2022, Sci Rep CrossRef
57. A pyroptosis expression pattern score predicts prognosis and immune microenvironment of lung squamous cell carcinoma
    Wei Chen et al, 2022, Front. Genet. CrossRef
58. Maternal Serum Gasdermin D Concentrations in Pregnancies Complicated by Isolated Intrauterine Growth Restriction
    Berna Buse Kobal et al, 2022, Z Geburtshilfe Neonatol CrossRef
59. Targeted Pyroptosis Is a Potential Therapeutic Strategy for Cancer
    Hao Wu et al, 2022, Journal of Oncology CrossRef
60. Intestinal Gasdermins for regulation of inflammation and tumorigenesis
    Wenbin Gong et al, 2022, Front. Immunol. CrossRef
61. Prognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma
    Lu-Shan Peng et al, 2022, Front. Oncol. CrossRef
62. Pyroptosis: A new insight of non-small-cell lung cancer treatment
    Xi Chen et al, 2022, Front. Oncol. CrossRef
63. A Novel Defined Pyroptosis-Related Gene Signature for Predicting the Prognosis of Endometrial Cancer
    Shuguang Liu et al, 2022, Disease Markers CrossRef
64. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective
    Muhammad Khan et al, 2022, Front. Immunol. CrossRef
65. NLRP3 inflammasome activation By 17β-estradiol is a potential therapeutic target in hepatocellular carcinoma treatment
    Sara F. Awwad et al, 2023, Med Oncol CrossRef
66. An emerging role of inflammasomes in spinal cord injury and spinal cord tumor
    Jiansong Chen et al, 2023, Front. Immunol. CrossRef
67. Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma
    Zhengsong Jiang et al, 2023 CrossRef
68. Inflammasomes driven inflammation in lung cancer revisited: a short review
    Vitor Rodrigues da Costa et al, 2023, Explor Immunol CrossRef
69. A novel risk score model based on pyroptosis-related genes for predicting survival and immunogenic landscape in hepatocellular carcinoma
    Hongyu Wang et al, 2023, Aging CrossRef
70. A novel pyroptosis-related prognostic signature for lung adenocarcinoma: Identification and multi-angle verification
    Xinyue Wang et al, 2023, Front. Genet. CrossRef
71. Pyroptosis and its role in cancer
    Shi-Wei Liu et al, 2023, World J Clin Cases CrossRef
72. Pyroptosis, metabolism and oxidation in tumorigenesis: mechanisms and therapeutic implications
    Qi Cao et al, 2023, Antioxidants & Redox Signaling CrossRef
73. Blocking CXC Motif Chemokine Ligand 2 Ameliorates Diabetic Peripheral Neuropathy via Inhibiting Apoptosis and NLRP3 Inflammasome Activation
    Yu Zhang et al, 2023, Biological & Pharmaceutical Bulletin CrossRef
74. Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors
    Zhen Dai et al, 2023, Front. Immunol. CrossRef
75. Construction of a novel pyrotosis-related prognostic model of esophageal square cell carcinoma and determination of the anti-tumor effect of WFDC12
    Yu Zhuang et al, 2023, Funct Integr Genomics CrossRef
76. The Pyroptotic and Nonpyroptotic Roles of Gasdermins in Modulating Cancer Progression and Their Perspectives on Cancer Therapeutics
    Sheng-Kai Hsu et al, 2023, Arch. Immunol. Ther. Exp. CrossRef
77. Identification of Pyroptosis Gene Signature Related Molecular Pattern, Clinical Implication, and Tumor Immunity in Hepatocellular Carcinoma`
    Yao-Ting Li et al, 2023, CCHTS CrossRef
78. Pyroptosis-related noncoding RNAs and cancer involvement
    Binshu Chai et al, 2023 CrossRef
79. A novel defined pyroptosis-related gene signature predicts prognosis and correlates with the tumour immune microenvironment in lung adenocarcinoma
    Zi Chen et al, 2023, Sci Rep CrossRef
80. Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function
    Jichi Zhang et al, 2023, Front. Oncol. CrossRef
81. Pyroptosis Inhibition in Disease Treatment: Opportunities and Challenges
    Navya Bandharam et al, 2023, Cell Biochem Biophys CrossRef
82. Pyroptosis: shedding light on the mechanisms and links with cancers
    Hong-mei You et al, 2023, Front. Immunol. CrossRef
83. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma
    Shixin Zhao et al, 2023, J Transl Med CrossRef
84. Identification of a potential prognostic model combining pyroptosis-related gene with immune microenvironment for pancreatic ductal adenocarcinoma
    Haoran Xie et al, 2023, J Cancer Res Clin Oncol CrossRef
85. The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment
    Mengyuan Li et al, 2023, Exp Hematol Oncol CrossRef
86. A pyroptosis-related signature in colorectal cancer: exploring its prognostic value and immunological characteristics
    Peicheng Jiang et al, 2023 CrossRef
87. The pyroptosis-related signature predicts prognosis and influences the tumor immune microenvironment in dedifferentiated liposarcoma
    Wenjing Chen et al, 2024 CrossRef
88. Gasdermins: a dual role in pyroptosis and tumor immunity
    Jiayi Yang et al, 2024, Front. Immunol. CrossRef
89. Silencing MFHAS1 Induces Pyroptosis via the JNK-activated NF-κB/Caspase1/ GSDMD Signal Axis in Breast Cancer
    Yue Jin et al, 2023, CPD CrossRef
90. Research Progress of GSDMD in Tumors
    鹏伟 白, 2024, ACM CrossRef